Pfizer, Moderna and US Patent Office
Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U.S. Patent Office tribunal that two patents Moderna accused them of infringing were invalid.
CNET on MSN15h
How the 3 New COVID Vaccines Change the Way You PayNow that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and ...
Axios on MSN4h
States push fight against mRNA vaccinesThe mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...
I asked the rheumatologist if it could be linked to the Pfizer vaccine and booster, and she said, ‘Yes, and you’re not the only patient I have who’s had this sequence of ...
The Iowa Senate bill alters a proposal that would have penalized administering gene-based vaccines including the COVID-19 ...
A small study on Covid vaccine safety has sparked an online tempest — and highlighted the conundrum faced by some scientists.
It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...
COVID-19 vaccines target emerging variants, offering improved protection. Learn about their effectiveness, timing, and safety ...
If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per violation.
Eighteen former city employees have taken their case to federal court after suing Bellingham for being terminated over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback